Taiwan
Also, Malaysian telehealth startup Qmed Asia has signed multiple partnerships around Asia.
It can diagnose diabetic retinopathy and diabetic macular oedema in 5-10 seconds.
Also, Royal Philips has expanded the roll-out of its AR surgical navigation solution to Japan.
Also, Point Robotics from Taiwan has received a US FDA 510(k) clearance for its surgical robot system.
Also, Olympus has come up with the third-generation Visera Elite surgical visualisation platform for endoscopic procedures.
Also, Lunit has received Taiwan's approval for its AI mammography solution.
This comes after it launched its CDI tool called DxPrime in June.
![[Left] Ed Deng, co-founder and CEO, Health2Sync; and [Right] Claudio Longo, President, AstraZeneca Taiwan](/sites/mhn/files/styles/230x130/public/2025-07/%2528Left%2529%2520Ed%2520Deng%252C%2520Co-founder%2520and%2520CEO%2520of%2520Health2Sync%2520and%2520%2528Right%2529%2520Claudio%2520Longo%252C%2520President%2520of%2520AstraZeneca%2520Taiwan.jpg?itok=XO7M1UnC)
Health2Sync has upgraded its patient management platform to identify patients' CKD risk levels.
It will be the first integration of Lunit's AI radiology software into an insurance underwriting workflow.
The AI solution has been trained based on a data set of 3.2 billion patient visits.